• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,802.90 -607.08
( -0.78%)
Global Indices
Nasdaq
51,584.84 71.29
(0.14%)
Dow Jones
7,519.91 78.81
(1.06%)
Hang Seng
70,971.12 -82.37
(-0.12%)
Nikkei 225
10,357.71 -41.99
(-0.40%)
Forex
USD-INR
94.51 -0.04
(-0.04%)
EUR-INR
109.43 -0.23
(-0.21%)
GBP-INR
126.51 -0.33
(-0.26%)
JPY-INR
0.59 0.00
(-0.05%)

EQUITY - MARKET SCREENER

Gland Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
543245
INE068V01023
655.3150344
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAND
27.56
36306.8
EPS(TTM)
Face Value()
Div & Yield %
79.87
1
0.91
 

zenotech laboratories ltd
Anant Raj consolidated net profit rises 23.57% in the March 2026 quarter
May 12,2026
Net profit of Anant Raj rose 23.57% to Rs 146.60 crore in the quarter ended March 2026 as against Rs 118.64 crore during the previous quarter ended March 2025. Sales rose 19.64% to Rs 646.81 crore in the quarter ended March 2026 as against Rs 540.65 crore during the previous quarter ended March 2025.

For the full year,net profit rose 30.39% to Rs 554.85 crore in the year ended March 2026 as against Rs 425.54 crore during the previous year ended March 2025. Sales rose 21.92% to Rs 2511.60 crore in the year ended March 2026 as against Rs 2059.97 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales646.81540.65 20 2511.602059.97 22
OPM %25.8826.33 -26.1123.87 -
PBDT192.22149.64 28 710.80520.99 36
PBT175.35140.93 24 661.94490.53 35
NP146.60118.64 24 554.85425.54 30